HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications

Background: Hepatocellular carcinoma (HCC) poses a major challenge because of the extreme variability of the clinical outcome, which makes it difficult to properly stage the disease and thereby estimate the prognosis. There is growing evidence that this heterogeneous clinical behavior is attributabl...

Full description

Saved in:
Bibliographic Details
Main Authors: Emilia Fransvea, Angelo Paradiso, Salvatore Antonaci, Gianluigi Giannelli
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0473
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565165908819968
author Emilia Fransvea
Angelo Paradiso
Salvatore Antonaci
Gianluigi Giannelli
author_facet Emilia Fransvea
Angelo Paradiso
Salvatore Antonaci
Gianluigi Giannelli
author_sort Emilia Fransvea
collection DOAJ
description Background: Hepatocellular carcinoma (HCC) poses a major challenge because of the extreme variability of the clinical outcome, which makes it difficult to properly stage the disease and thereby estimate the prognosis. There is growing evidence that this heterogeneous clinical behavior is attributable to several different biological pathways. A novel approach to mapping these differences is by investigating the epigenetics associated with certain clinical aspects.
format Article
id doaj-art-5ca561749df3490db86a20c90e4ca3dd
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-5ca561749df3490db86a20c90e4ca3dd2025-02-03T01:09:10ZengWileyCellular Oncology1570-58701875-86062009-01-0131322723310.3233/CLO-2009-0473HCC Heterogeneity: Molecular Pathogenesis and Clinical ImplicationsEmilia Fransvea0Angelo Paradiso1Salvatore Antonaci2Gianluigi Giannelli3Department of Internal Medicine, Immunology, and Infectious Diseases, Section of Internal Medicine, University of Bari Medical School, Bari, ItalyClinical Experimental Oncology Laboratory, National Cancer Institute, Bari, ItalyDepartment of Internal Medicine, Immunology, and Infectious Diseases, Section of Internal Medicine, University of Bari Medical School, Bari, ItalyDepartment of Internal Medicine, Immunology, and Infectious Diseases, Section of Internal Medicine, University of Bari Medical School, Bari, ItalyBackground: Hepatocellular carcinoma (HCC) poses a major challenge because of the extreme variability of the clinical outcome, which makes it difficult to properly stage the disease and thereby estimate the prognosis. There is growing evidence that this heterogeneous clinical behavior is attributable to several different biological pathways. A novel approach to mapping these differences is by investigating the epigenetics associated with certain clinical aspects.http://dx.doi.org/10.3233/CLO-2009-0473
spellingShingle Emilia Fransvea
Angelo Paradiso
Salvatore Antonaci
Gianluigi Giannelli
HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
Cellular Oncology
title HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
title_full HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
title_fullStr HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
title_full_unstemmed HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
title_short HCC Heterogeneity: Molecular Pathogenesis and Clinical Implications
title_sort hcc heterogeneity molecular pathogenesis and clinical implications
url http://dx.doi.org/10.3233/CLO-2009-0473
work_keys_str_mv AT emiliafransvea hccheterogeneitymolecularpathogenesisandclinicalimplications
AT angeloparadiso hccheterogeneitymolecularpathogenesisandclinicalimplications
AT salvatoreantonaci hccheterogeneitymolecularpathogenesisandclinicalimplications
AT gianluigigiannelli hccheterogeneitymolecularpathogenesisandclinicalimplications